Beyond the Scan: Why Timely Information Matters in Cancer Care

On PET imaging, patient advocacy, the cost of seeking answers, and why access to information is an essential part of compassionate healthcare.

When you're living with cancer, particularly metastatic cancer, you quickly learn that information is everything.

Not just any information.

The right information, at the right time, delivered in a way that allows you to make meaningful decisions about your care.

Because when you're navigating a life-limiting diagnosis, time isn't an abstract concept.

It's deeply personal.

It's time with your children. Time with your partner. Time to experience the ordinary moments that suddenly feel extraordinary.

And it's time to determine whether a treatment is working, whether something needs to change, or whether the path you're on is still the right one.

I've experienced what it feels like to wait for answers that seem impossibly far away.

I've also experienced the extraordinary relief that comes with having timely, detailed imaging results that help bring clarity to an otherwise uncertain situation.

And those experiences have fundamentally shaped how I think about patient advocacy, diagnostic imaging, and what compassionate healthcare should look like.

Because access to information isn't simply a medical consideration. It's a human one.

When Information Changes Everything

Since my metastatic breast cancer diagnosis, imaging has become an essential part of understanding what is happening inside my body (currently I am scanned every 3 months).

PET scans, MRIs, bloodwork, tumour markers — each provides a different piece of an extraordinarily complicated puzzle.

And while no single test tells the entire story, together they help inform the decisions that shape my treatment.

I've experienced disease progression that required a change in therapy.

I've also experienced the immense relief of seeing evidence that a treatment is working.

Both experiences have reinforced the importance of monitoring disease thoughtfully and consistently.

When you're living with metastatic cancer, the goal isn't simply to identify whether cancer exists.

We already know that.

The questions become much more specific.

Is the current treatment controlling the disease?

Are existing lesions responding?

Has something new appeared?

Are we seeing meaningful changes that warrant a different approach?

And perhaps most importantly, what do these findings mean for the decisions we make next?

For me, having access to detailed imaging has helped transform some of those questions into more informed conversations with my oncology team.

It doesn't eliminate uncertainty.

But it gives us something tangible to work with.

The Difference PET Imaging Has Made in My Journey

I've been fortunate to access PET imaging through Initio Medical Group, and that experience has significantly shaped my understanding of what timely diagnostic care can look like.

There is something so comforting about walking into an imaging appointment knowing that, within a relatively short period, you may have a clearer understanding of how your disease is behaving.

I know the routine now. I am a pro.

The preparation. The fasting. The waiting. The quiet moments before the scan begins.

And then, of course, the anticipation of the results.

Anyone who has experienced scan anxiety understands that the emotional weight of imaging doesn't begin or end with the appointment itself.

It lives in the days leading up to the scan.

It follows you into conversations with your family.

It sits quietly in the background while you attempt to carry on with everyday life.

And sometimes, the waiting is almost as difficult as the information itself.

What I've valued about my experience with Initio is the opportunity to access detailed imaging and timely information that can be brought into conversations about my care.

I've come to appreciate the importance of continuity, consistency, and having access to professionals who understand the significance of these results.

Not because every scan brings good news.

It doesn't.

But because I would rather understand what I'm dealing with than remain unnecessarily in the dark.

Clarity isn't always comforting. But it can be empowering.

PET Scans: An Important Tool, Not a Universal Answer

One of the things I've become increasingly passionate about is access to advanced diagnostic imaging.

In British Columbia, PET/CT scans are publicly funded for specific approved clinical indications. However, not every cancer diagnosis or monitoring scenario meets those criteria.

That distinction matters.

PET imaging isn't automatically the best tool for every patient or every clinical situation.

Different imaging technologies provide different types of information.

CT scans can show anatomical changes, including the size and structure of lesions.

MRI provides detailed imaging of soft tissues and is particularly important in evaluating areas such as the brain.

FDG PET/CT combines anatomical imaging with information about metabolic activity, helping clinicians evaluate certain cancers and, in appropriate circumstances, assess treatment response.

Each has its place.

And each has limitations.

But for some patients, particularly those navigating complex metastatic disease, PET imaging can provide clinically valuable information that may not be as readily apparent through other imaging approaches.

In metastatic breast cancer, research and professional imaging guidelines recognize that PET/CT can play a role in evaluating disease extent and treatment response, including in patients with bone metastases.

So the conversation shouldn't simply be about whether PET scans are necessary for everyone.

It should be about whether patients who could meaningfully benefit from this technology are able to access it in a timely and equitable way.

The right test, for the right patient, at the right time.

That is the standard I believe in.

When Access to Information Comes With a Price Tag

There's another reality that deserves more attention.

The financial cost of seeking additional information.

When you're living with a complex diagnosis, you may find yourself considering imaging, consultations, specialist reviews, and additional medical opinions outside the publicly funded system.

Sometimes these services provide valuable information.

Sometimes they confirm what is already known.

And sometimes the additional expense doesn't translate into a meaningful change in treatment.

I've experienced all the complexity that comes with making those decisions.

Over time, I've invested significant financial resources into additional consultations, imaging, integrative care, and supportive treatments.

And I've learned that more information isn't automatically better information.

A more detailed report doesn't necessarily change the treatment plan.

An additional interpretation doesn't always provide new clinical insight.

And a service that was valuable at one point in your journey may not remain necessary indefinitely.

I've had to learn to ask harder questions.

What am I hoping to learn?

Will this information change a clinical decision?

Does it offer meaningful value beyond what I already know?

And is that value worth the financial investment?

These are especially difficult questions when the stakes feel so high.

Because when you're living with metastatic cancer, the desire to leave no stone unturned can be overwhelming.

But resources are finite.

And I believe patients deserve greater transparency about both the clinical value and financial implications of additional diagnostic services.

Access to meaningful information shouldn't depend solely on someone's ability to pay.

At the same time, advocating for access also means advocating for appropriate use, thoughtful decision-making, and care that genuinely serves the patient.

More Than Medicine: It's Humanity

One of the most important lessons I've learned is that compassionate healthcare extends far beyond the treatment itself.

It's how information is communicated.

It's whether questions are welcomed.

It's whether patients feel included in decisions.

It's whether someone takes the time to explain why a particular test is recommended — or why it isn't.

I've encountered extraordinary healthcare professionals who have demonstrated what patient-centred care can look like.

And I've also experienced moments when I've had to push harder than I expected to understand my options.

I don't believe every disagreement between a patient and a clinician represents a failure of care.

Medicine is complicated.

Clinical decisions must consider evidence, risks, available resources, and individual circumstances.

But I do believe patients deserve thoughtful explanations rather than feeling dismissed for asking questions.

When someone is living with cancer, their desire for clarity isn't unreasonable.

It's human.

And while information doesn't guarantee reassurance, being informed can help restore a sense of agency in a situation where so much feels outside your control.

I may not control what a scan reveals, but I deserve to understand what it means and participate in deciding what happens next.

Becoming an Advocate for Your Own Care

Before cancer, I understood advocacy largely through the lens of sport.

As an Olympic athlete, I learned the importance of preparation, discipline, asking questions, and surrounding myself with knowledgeable people.

But advocating for yourself as a patient is an entirely different experience.

There is an emotional vulnerability that comes with navigating decisions about your own survival.

You aren't simply evaluating performance or pursuing a competitive goal.

You're making decisions that affect your health, your family, your quality of life, and potentially your future.

I've learned that being an effective advocate doesn't mean challenging every recommendation or pursuing every available intervention.

It means becoming an informed participant.

Understanding why a test is being recommended.

Asking what the results might change.

Seeking clarification when something doesn't make sense.

Recognizing when another perspective may be valuable.

And remaining open to the possibility that the best decision may sometimes be to wait, reassess, or choose a different approach.

I've also learned that self-advocacy shouldn't require becoming a medical expert.

Patients are already carrying enough.

We deserve healthcare systems that help us navigate complexity rather than leaving us to manage every uncertainty on our own.

What I Hope Changes

My experience has made me increasingly aware of the gap that can exist between medical innovation and patient access.

We live in a time of remarkable advances in cancer diagnostics and treatment.

New therapies are emerging.

Imaging technologies continue to evolve.

Our understanding of cancer biology is becoming increasingly sophisticated.

And yet, access to those advances can vary considerably depending on where someone lives, their diagnosis, clinical eligibility, and financial circumstances.

I believe there is room for improvement.

I would love to see continued evaluation of PET imaging criteria as evidence evolves, greater consistency in access to appropriate diagnostic services, and more transparent conversations about imaging options.

I would also love to see a healthcare culture that recognizes the emotional value of timely communication.

Because while not every scan is necessary, every patient deserves to understand the reasoning behind their care.

And when imaging can meaningfully influence treatment decisions, unnecessary barriers and delays deserve serious attention.

This isn't about demanding every available technology.

It's about making sure that the tools we have are being used thoughtfully, fairly, and in ways that genuinely benefit patients.

A Note to Anyone Waiting for Answers

If you're reading this while navigating your own cancer diagnosis, I want you to know that you're allowed to ask questions.

You're allowed to request clarification.

You're allowed to ask whether another imaging option might be appropriate.

You're allowed to seek another medical opinion.

And you're allowed to express how difficult the uncertainty feels.

You don't have to understand every technical detail of your diagnosis to deserve a meaningful role in your care.

You don't have to agree with every recommendation without understanding the reasoning.

And you don't have to apologize for wanting to know what's happening inside your body.

But I also want to remind you of something I've had to learn myself.

More testing doesn't always mean better care.

More information doesn't always mean more certainty.

And sometimes the most important thing isn't obtaining another result, but having a healthcare professional who can help you understand the information already available.

For me, this journey has reinforced a belief that continues to guide how I navigate my health:

Knowledge is powerful. But knowledge combined with compassion, clinical expertise, and meaningful patient involvement is where healthcare becomes truly human.

I'll continue asking questions.

I'll continue advocating for timely, appropriate access to diagnostic imaging.

And I'll continue being grateful for the people and organizations, including Initio Medical Group, who have helped me navigate the uncertainty with greater clarity.

Because at the end of the day, this isn't just about scans, statistics, or treatment protocols.

It's about people.

It's about dignity.

It's about having the information and support we need to make thoughtful decisions about the lives we're working so hard to live.

And that, to me, is what compassionate healthcare should be.

xo,

K.